4
Changes in Ownership
Inhibikase Therapeutics, Inc. Filed Acc 0000950170-25-007742
Options or other derivatives
- Director acquired 70,106 shares (grant or award)
- Director returned 70,106 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Freeman Roy Lester Director | 2025-01-21 | Returned to the company · Stock Option (Right to Buy) | −21,854 | 0 | D: show line 1 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Grant or award · Stock Option (Right to Buy) | +21,854 | 21,854 | D: show line 2 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Returned to the company · Stock Option (Right to Buy) | −1,138 | 0 | D: show line 3 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Grant or award · Stock Option (Right to Buy) | +1,138 | 1,138 | D: show line 4 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Returned to the company · Stock Option (Right to Buy) | −3,780 | 0 | D: show line 5 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Grant or award · Stock Option (Right to Buy) | +3,780 | 3,780 | D: show line 6 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Returned to the company · Stock Option (Right to Buy) | −6,667 | 0 | D: show line 7 in the form | |||||
| Freeman Roy Lester Director | 2025-01-21 | Grant or award · Stock Option (Right to Buy) | +6,667 | 6,667 | D: show line 8 in the form |
Loading xslF345X05/ownership.xml…